Sorgenfrei IF, Norrild K, Larsen PB, et al. Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex. A dose-finding and safety study. Anesthesiology 2006; 104: 667-74.
Groudine SB, Soto R, Lien C, et al. A randomized, dose-finding, phase II study of the selective relaxant binding drugs, sugammadex, capable of safely reversing profound rocuronium-induced neuromuscular block. Anesth Analg 2007; 104: 555-62.
Pühringer FK, Rex C, Sielenkämper AW, et al. Reversal of profound, highdose rocuronium-induced neuromuscular blockade by sugammadex at two different time points. An international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial. Anesthesiology 2008; 109: 188-97.
Lee C, Jahr JS, Candiotti KA, et al. Reversal of profound neuromuscular block by sugammadex administered three minutes after rocuronium. A comparison with spontaneous recovery from succinylcholine. Anesthesiology 2009; 110: 1020-5.